FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 338:653-662 March 5, 1998 Number 10 Next

Inactivating Mutations in the 25-Hydroxyvitamin D3 1-Hydroxylase Gene in Patients with Pseudovitamin D–Deficiency Rickets

	Full Text PDF Editorial by Bouillon, R. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Pseudovitamin D–deficiency rickets is characterized by the early onset of rickets with hypocalcemia and is thought to be caused by a deficit in renal 25-hydroxyvitamin D₃ 1-hydroxylase, the key enzyme for the synthesis of 1,25-dihydroxyvitamin D₃.

Methods We cloned human 25-hydroxyvitamin D₃ 1-hydroxylase complementary DNA (cDNA) using a mouse 1-hydroxylase cDNA fragment as a probe. Its genomic structure was determined, and its chromosomal location was mapped by fluorescence in situ hybridization. We then identified mutations in the 1-hydroxylase gene in four unrelated patients with pseudovitamin D–deficiency rickets by DNA-sequence analysis. Both the normal and the mutant 1-hydroxylase proteins were expressed in COS-1 cells and were assayed for 1-hydroxylase activity.

Results The gene for 25-hydroxyvitamin D₃ 1-hydroxylase was mapped to chromosome 12q13.3, which had previously been reported to be the locus for pseudovitamin D–deficiency rickets by linkage analysis. Four different homozygous missense mutations were detected in this gene in the four patients with pseudovitamin D–deficiency rickets. The unaffected parents and one sibling tested were heterozygous for the mutations. Functional analysis of the mutant 1-hydroxylase protein revealed that all four mutations abolished 1-hydroxylase activity.

Conclusions Inactivating mutations in the 25-hydroxyvitamin D₃ 1-hydroxylase gene are a cause of pseudovitamin D–deficiency rickets.

Source Information

From the Institute of Molecular and Cellular Biosciences, University of Tokyo, Tokyo (S. Kitanaka, K.T., A.M., T.S., J.Y., S. Kato); Core Research for Evolutional Science and Technology, Japan Science and Technology Corporation, Saitama (S. Kato); the Faculty of Bioresources, Mie University, Mie (K.O., M.N.); Tokyo Metropolitan Kiyose Children's Hospital, Tokyo (Y.H.); the Department of Pediatrics, Chiba University School of Medicine, Chiba (H.N.); and the Department of Endocrinology and Metabolism, National Children's Medical Research Center, Tokyo (T.T.) — all in Japan.

Address reprint requests to Dr. Kato at the Institute of Molecular and Cellular Biosciences, University of Tokyo, Yayoi, Bunkyo-ku, Tokyo 113-0032, Japan.

Full Text of this Article

This article has been cited by other articles:

• Zhong, Y., Armbrecht, H. J., Christakos, S. (2009). Calcitonin, a Regulator of the 25-Hydroxyvitamin D3 1{alpha}-Hydroxylase Gene. J. Biol. Chem. 284: 11059-11069 [Abstract] [Full Text]  
• Bouillon, R., Carmeliet, G., Verlinden, L., van Etten, E., Verstuyf, A., Luderer, H. F., Lieben, L., Mathieu, C., Demay, M. (2008). Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice. Endocr. Rev. 29: 726-776 [Abstract] [Full Text]  
• Bailey, R., Cooper, J. D., Zeitels, L., Smyth, D. J., Yang, J. H.M., Walker, N. M., Hypponen, E., Dunger, D. B., Ramos-Lopez, E., Badenhoop, K., Nejentsev, S., Todd, J. A. (2007). Association of the Vitamin D Metabolism Gene CYP27B1 With Type 1 Diabetes. Diabetes 56: 2616-2621 [Abstract] [Full Text]  
• Kim, C. J., Kaplan, L. E., Perwad, F., Huang, N., Sharma, A., Choi, Y., Miller, W. L., Portale, A. A. (2007). Vitamin D 1{alpha}-Hydroxylase Gene Mutations in Patients with 1{alpha}-Hydroxylase Deficiency. J. Clin. Endocrinol. Metab. 92: 3177-3182 [Abstract] [Full Text]  
• Holick, M. F. (2007). Vitamin D Deficiency. NEJM 357: 266-281 [Full Text]  
• Vanhooke, J. L., Prahl, J. M., Kimmel-Jehan, C., Mendelsohn, M., Danielson, E. W., Healy, K. D., DeLuca, H. F. (2006). CYP27B1 null mice with LacZreporter gene display no 25-hydroxyvitamin D3-1{alpha}-hydroxylase promoter activity in the skin. Proc. Natl. Acad. Sci. USA 103: 75-80 [Abstract] [Full Text]  
• Xie, Z., Chang, S., Oda, Y., Bikle, D. D. (2006). Hairless Suppresses Vitamin D Receptor Transactivation in Human Keratinocytes. Endocrinology 147: 314-323 [Abstract] [Full Text]  
• Renkema, K. Y., Nijenhuis, T., van der Eerden, B. C.J., van der Kemp, A. W.C.M., Weinans, H., van Leeuwen, J. P.T.M., Bindels, R. J.M., Hoenderop, J. G.J. (2005). Hypervitaminosis D Mediates Compensatory Ca2+ Hyperabsorption in TRPV5 Knockout Mice. J. Am. Soc. Nephrol. 16: 3188-3195 [Abstract] [Full Text]  
• Yamamoto, K., Uchida, E., Urushino, N., Sakaki, T., Kagawa, N., Sawada, N., Kamakura, M., Kato, S., Inouye, K., Yamada, S. (2005). Identification of the Amino Acid Residue of CYP27B1 Responsible for Binding of 25-Hydroxyvitamin D3 Whose Mutation Causes Vitamin D-dependent Rickets Type 1. J. Biol. Chem. 280: 30511-30516 [Abstract] [Full Text]  
• Dusso, A. S., Brown, A. J., Slatopolsky, E. (2005). Vitamin D. Am. J. Physiol. Renal Physiol. 289: F8-F28 [Abstract] [Full Text]  
• Skorija, K., Cox, M., Sisk, J. M., Dowd, D. R., MacDonald, P. N., Thompson, C. C., Demay, M. B. (2005). Ligand-Independent Actions of the Vitamin D Receptor Maintain Hair Follicle Homeostasis. Mol. Endocrinol. 19: 855-862 [Abstract] [Full Text]  
• Levine, A. M., Tulpule, A., Espina, B., Sherrod, A., Boswell, W. D., Lieberman, R. D., Nathwani, B. N., Welles, L. (2004). Liposome-Encapsulated Doxorubicin in Combination With Standard Agents (cyclophosphamide, vincristine, prednisone) in Patients With Newly Diagnosed AIDS-Related Non-Hodgkin's Lymphoma: Results of Therapy and Correlates of Response. JCO 22: 2662-2670 [Abstract] [Full Text]  
• Yamasaki, T., Izumi, S., Ide, H., Ohyama, Y. (2004). Identification of a Novel Rat Microsomal Vitamin D3 25-Hydroxylase. J. Biol. Chem. 279: 22848-22856 [Abstract] [Full Text]  
• Kitanaka, S., Miki, Y., Hayashi, Y., Igarashi, T. (2004). Promoter-Specific Repression of Hepatocyte Nuclear Factor (HNF)-1{beta} and HNF-1{alpha} Transcriptional Activity by an HNF-1{beta} Missense Mutant Associated with Type 5 Maturity-Onset Diabetes of the Young with Hepatic and Biliary Manifestations. J. Clin. Endocrinol. Metab. 89: 1369-1378 [Abstract] [Full Text]  
• Zanello, L. P., Norman, A. W. (2004). Rapid modulation of osteoblast ion channel responses by 1{alpha},25(OH)2-vitamin D3 requires the presence of a functional vitamin D nuclear receptor. Proc. Natl. Acad. Sci. USA 101: 1589-1594 [Abstract] [Full Text]  
• Kip, S. N., Strehler, E. E. (2004). Vitamin D3 upregulates plasma membrane Ca2+-ATPase expression and potentiates apico-basal Ca2+ flux in MDCK cells. Am. J. Physiol. Renal Physiol. 286: F363-F369 [Abstract] [Full Text]  
• Yokomura, K., Suda, T., Sasaki, S., Inui, N., Chida, K., Nakamura, H. (2003). Increased Expression of the 25-Hydroxyvitamin D3-1{alpha}-Hydroxylase Gene in Alveolar Macrophages of Patients with Lung Cancer. J. Clin. Endocrinol. Metab. 88: 5704-5709 [Abstract] [Full Text]  
• van Abel, M., Hoenderop, J. G. J., van der Kemp, A. W. C. M., van Leeuwen, J. P. T. M., Bindels, R. J. M. (2003). Regulation of the epithelial Ca2+ channels in small intestine as studied by quantitative mRNA detection. Am. J. Physiol. Gastrointest. Liver Physiol. 285: G78-G85 [Abstract] [Full Text]  
• Singh, J, Moghal, N, Pearce, S H S, Cheetham, T (2003). The investigation of hypocalcaemia and rickets. Arch. Dis. Child. 88: 403-407 [Abstract] [Full Text]  
• Katsumata, N., Ohtake, M., Hojo, T., Ogawa, E., Hara, T., Sato, N., Tanaka, T. (2002). Compound Heterozygous Mutations in the Cholesterol Side-Chain Cleavage Enzyme Gene (CYP11A) Cause Congenital Adrenal Insufficiency in Humans. J. Clin. Endocrinol. Metab. 87: 3808-3813 [Abstract] [Full Text]  
• Carpenter, T. O. (2002). Variable Degrees of 1-{alpha} Hydroxylase Activity--Fine Tuning the Rachitic Rheostat. J. Clin. Endocrinol. Metab. 87: 2421-2423 [Full Text]  
• Wang, X., Zhang, M. Y. H., Miller, W. L., Portale, A. A. (2002). Novel Gene Mutations in Patients with 1{alpha}-Hydroxylase Deficiency That Confer Partial Enzyme Activity in Vitro. J. Clin. Endocrinol. Metab. 87: 2424-2430 [Abstract] [Full Text]  
• Yoshida, T., Yoshino, J., Hayashi, M., Saruta, T. (2002). Identification of a Renal Proximal Tubular Cell-Specific Enhancer in the Mouse 25-Hydroxyvitamin D 1{alpha}-Hydroxylase Gene. J. Am. Soc. Nephrol. 13: 1455-1463 [Abstract] [Full Text]  
• Kato, S. (2001). Editorial: Vitamin D 1{{alpha}}-Hydroxylase Knockout Mice as a Hereditary Rickets Animal Model. Endocrinology 142: 2734-2735 [Full Text]  
• Dardenne, O., Prud'homme, J., Arabian, A., Glorieux, F. H., St-Arnaud, R. (2001). Targeted Inactivation of the 25-Hydroxyvitamin D3-1{{alpha}}-Hydroxylase Gene (CYP27B1) Creates an Animal Model of Pseudovitamin D-Deficiency Rickets. Endocrinology 142: 3135-3141 [Abstract] [Full Text]  
• Yamagata, M., Kimoto, A., Michigami, T., Nakayama, M., Ozono, K. (2001). Hydroxylases Involved in Vitamin D Metabolism Are Differentially Expressed in Murine Embryonic Kidney: Application of Whole Mount in Situ Hybridization. Endocrinology 142: 3223-3230 [Abstract] [Full Text]  
• HOENDEROP, J. G. J., MULLER, D., VAN DER KEMP, A. W. C. M., HARTOG, A., SUZUKI, M., ISHIBASHI, K., IMAI, M., SWEEP, F., WILLEMS, P. H. G. M., OS, C. H. V., BINDELS, R. J. M. (2001). Calcitriol Controls the Epithelial Calcium Channel in Kidney. J. Am. Soc. Nephrol. 12: 1342-1349 [Abstract] [Full Text]  
• Panda, D. K., Miao, D., Tremblay, M. L., Sirois, J., Farookhi, R., Hendy, G. N., Goltzman, D. (2001). Targeted ablation of the 25-hydroxyvitamin D 1alpha -hydroxylase enzyme: Evidence for skeletal, reproductive, and immune dysfunction. Proc. Natl. Acad. Sci. USA 98: 7498-7503 [Abstract] [Full Text]  
• Tenenhouse, H. S., Martel, J., Gauthier, C., Zhang, M. Y. H., Portale, A. A. (2001). Renal Expression of the Sodium/Phosphate Cotransporter Gene, Npt2, Is Not Required for Regulation of Renal 1{{alpha}}-Hydroxylase by Phosphate. Endocrinology 142: 1124-1129 [Abstract] [Full Text]  
• Zehnder, D., Bland, R., Williams, M. C., McNinch, R. W., Howie, A. J., Stewart, P. M., Hewison, M. (2001). Extrarenal Expression of 25-Hydroxyvitamin D3-1{{alpha}}-Hydroxylase. J. Clin. Endocrinol. Metab. 86: 888-894 [Abstract] [Full Text]  
• Zargar, A. H., Mithal, A., Wani, A. I., Laway, B. A., Masoodi, S. R., Bashir, M. I., Ganie, M. A. (2000). Pseudovitamin D deficiency rickets---a report from the Indian subcontinent. Postgrad. Med. J. 76: 369-372 [Abstract] [Full Text]  
• YOSHIDA, N., YOSHIDA, T., NAKAMURA, A., MONKAWA, T., HAYASHI, M., SARUTA, T. (1999). Calcitonin Induces 25-Hydroxyvitamin D3 1{alpha}-Hydroxylase mRNA Expression via Protein Kinase C Pathway in LLC-PK1 Cells. J. Am. Soc. Nephrol. 10: 2474-2479 [Abstract] [Full Text]  
• Kitanaka, S., Murayama, A., Sakaki, T., Inouye, K., Seino, Y., Fukumoto, S., Shima, M., Yukizane, S., Takayanagi, M., Niimi, H., Takeyama, K.-i., Kato, S. (1999). No Enzyme Activity of 25-Hydroxyvitamin D3 1{alpha}-Hydroxylase Gene Product in Pseudovitamin D Deficiency Rickets, Including That with Mild Clinical Manifestation. J. Clin. Endocrinol. Metab. 84: 4111-4117 [Abstract] [Full Text]  
• Brown, A. J., Dusso, A., Slatopolsky, E. (1999). Vitamin D. Am. J. Physiol. Renal Physiol. 277: F157-F175 [Abstract] [Full Text]  
• Jones, G., Ramshaw, H., Zhang, A., Cook, R., Byford, V., White, J., Petkovich, M. (1999). Expression and Activity of Vitamin D-Metabolizing Cytochrome P450s (CYP1{alpha} and CYP24) in Human Nonsmall Cell Lung Carcinomas. Endocrinology 140: 3303-3310 [Abstract] [Full Text]  
• Kong, X. F., Zhu, X. H., Pei, Y. L., Jackson, D. M., Holick, M. F. (1999). Molecular cloning, characterization, and promoter analysis of the human 25-hydroxyvitamin D3-1alpha -hydroxylase gene. Proc. Natl. Acad. Sci. USA 96: 6988-6993 [Abstract] [Full Text]  
• John, E. M., Schwartz, G. G., Dreon, D. M., Koo, J. (1999). Vitamin D and Breast Cancer Risk: The NHANES I Epidemiologic Follow-up Study, 1971-1975 to 1992. Cancer Epidemiol. Biomarkers Prev. 8: 399-406 [Abstract] [Full Text]  
• Bland, R., Walker, E. A., Hughes, S. V., Stewart, P. M., Hewison, M. (1999). Constitutive Expression of 25-Hydroxyvitamin D3-1{alpha}-Hydroxylase in a Transformed Human Proximal Tubule Cell Line: Evidence for Direct Regulation of Vitamin D Metabolism by Calcium. Endocrinology 140: 2027-2034 [Abstract] [Full Text]  
• Murayama, A., Takeyama, K.-i., Kitanaka, S., Kodera, Y., Kawaguchi, Y., Hosoya, T., Kato, S. (1999). Positive and Negative Regulations of the Renal 25-Hydroxyvitamin D3 1{alpha}-Hydroxylase Gene by Parathyroid Hormone, Calcitonin, and 1{alpha},25(OH)2D3 in Intact Animals. Endocrinology 140: 2224-2231 [Abstract] [Full Text]  
• YOSHIDA, T., YOSHIDA, N., NAKAMURA, A., MONKAWA, T., HAYASHI, M., SARUTA, T. (1999). Cloning of Porcine 25-Hydroxyvitamin D3 1{alpha}-Hydroxylase and Its Regulation by cAMP in LLC-PK1 Cells. J. Am. Soc. Nephrol. 10: 963-970 [Abstract] [Full Text]  
• Malloy, P. J., Pike, J. W., Feldman, D. (1999). The Vitamin D Receptor and the Syndrome of Hereditary 1,25-Dihydroxyvitamin D-Resistant Rickets. Endocr. Rev. 20: 156-188 [Abstract] [Full Text]  
• Hoenderop, J. G. J., van der Kemp, A. W. C. M., Hartog, A., van de Graaf, S. F. J., van Os, C. H., Willems, P. H. G. M., Bindels, R. J. M. (1999). Molecular Identification of the Apical Ca2+ Channel in 1,25-Dihydroxyvitamin D3-responsive Epithelia. J. Biol. Chem. 274: 8375-8378 [Abstract] [Full Text]  
• Chesney, R. W. (1998). A New Form of Rickets During Infancy: Phosphate Depletion-Induced Osteopenia Due to Antacid Ingestion. Arch Pediatr Adolesc Med 152: 1168-1169 [Full Text]  
• Bouillon, R. (1998). The Many Faces of Rickets. NEJM 338: 681-682 [Full Text]  
• Chen, H., Hu, B., Allegretto, E. A., Adams, J. S. (2000). The Vitamin D Response Element-binding Protein. A NOVEL DOMINANT-NEGATIVE REGULATOR OF VITAMIN D-DIRECTED TRANSACTIVATION. J. Biol. Chem. 275: 35557-35564 [Abstract] [Full Text]